Circulating ADAMTS13 Levels Are Associated with an Increased Occurrence of Obstructive Sleep Apnea

Table 3

Multivariate logistic regression analysis of circulating ADAMTS13 levels and OSA.

	Unadjusted		Model 1		Model 2
	OR (95% CI)	value	OR (95% CI)	value	OR (95% CI)	value
ADAMTS13(per ng/mL increase)	10.695 (5.933-19.280)	<0.001	11.105 (5.753-21.434)	<0.001	13.305 (5.338-33.161)	<0.001

Model 1: adjusted for age, sex, BMI, CAD, and smoker. Model 2: adjusted for model 1+SBP, DBP, TG, TC, LDL, HDL, ALT, AST, GGT, uric acid, creatinine, and FBG. CI: confidence interval; OR: odds ratio; BMI: body mass index; CAD: coronary artery disease; DBP: diastolic blood pressure; SBP: systolic blood pressure; FBG: fasting blood glucose; GGT: γ-glutamyl transferase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; LDL: low-density lipoprotein cholesterol; ALT: alanine aminotransferase; AST: aspartate aminotransferase; OSA: obstructive sleep apnea; ADAMTS13: a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13.